Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 CAD | -1.28% | -3.02% | -2.53% |
05-09 | Transcript : HLS Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.53% | 89.59M | |
+21.26% | 72.45B | |
-4.56% | 23.46B | |
+4.89% | 8.59B | |
+7.83% | 8.35B | |
-21.35% | 7.88B | |
+15.08% | 5.21B | |
-1.97% | 4.11B | |
+10.84% | 4.09B | |
+20.72% | 3.6B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Executive Chair Bill Wells Retires, Gubitz to Become Board Chair